2020
Session 311
Grory S, Trevisan L, Kirwin P. Session 311. American Journal Of Geriatric Psychiatry 2020, 28: s29-s30. DOI: 10.1016/j.jagp.2020.01.056.Peer-Reviewed Original ResearchSubstance use disordersOlder individualsOlder personsComprehensive care modelPublic health concernField of geriatricsTreatment modalitiesGeriatric cohortCurrent treatment modelsCare modelUse disordersMeeting criteriaDrug useHealth problemsPsychiatric conditionsHealth concernIllicit substancesGeriatric psychiatryDrug habitsLater lifePrevious cohortTreatment modelIllicit drugsCohortHigh rate
2019
Substance Use Disorders in Later Life: A Review and Synthesis of the Literature of an Emerging Public Health Concern
Yarnell S, Li L, MacGrory B, Trevisan L, Kirwin P. Substance Use Disorders in Later Life: A Review and Synthesis of the Literature of an Emerging Public Health Concern. American Journal Of Geriatric Psychiatry 2019, 28: 226-236. PMID: 31340887, DOI: 10.1016/j.jagp.2019.06.005.Peer-Reviewed Original ResearchConceptsSubstance use disordersPublic health concernOlder individualsUse disordersDrug useOlder personsHealth concernGeriatric psychiatryComprehensive care modelLater lifeIllicit drugsField of geriatricsTreatment modalitiesGeriatric cohortCurrent treatment modelsCare modelMeeting criteriaHealth problemsPsychiatric conditionsSubstance abuseDrug dependencyIllicit substancesDrug abuseDrug habitsPrevious cohort
2017
Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions
Hassell C, Wilkins K, Trevisan L. Pharmacology of Geriatric Substance Use Disorders: Considerations and Future Directions. Current Treatment Options In Psychiatry 2017, 4: 102-115. DOI: 10.1007/s40501-017-0107-z.Peer-Reviewed Reviews, Practice Guidelines, Standards, and Consensus StatementsSubstance use disordersEvidence-based treatmentsUse disordersGeriatric populationEvidence-based pharmacological treatment optionsAvailable evidence-based treatmentsHigh-quality clinical trialsOlder adultsAvailable pharmacological treatmentsPharmacological treatment optionsLimitations of treatmentPharmacological treatmentTreatment optionsClinical trialsCertain drugsYoung adultsAdverse effectsDisordersTreatmentAdultsHigh rateUnique needsPopulationBaby boomer generationDysfunction